Freestone Grove Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$991K Buy
+3,713
New +$1.01M 0.01% 481
2025
Q3
Sell
-5,568
Closed -$1.46M 816
2025
Q2
$1.46M Sell
5,568
-158,819
-97% -$38.7M 0.01% 396
2025
Q1
$38.3M Sell
164,387
-47,948
-23% -$11.6M 0.39% 81
2024
Q4
$48.7M Buy
+212,335
New +$48.7M 0.6% 52

Other funds holding LH

Freestone Grove Partners's LH Position: Q1 2026 in Review

Freestone Grove Partners opened a new position in Labcorp (LH) in Q1 2026: 3,713 shares worth $991K. The stake represents 0.01% of the portfolio and ranks #481 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in LH as recently as Q2 2025.

Freestone Grove Partners first reported a position in LH in Q4 2024 and has held it in 4 quarters since. The position peaked at $48.7M in Q4 2024. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Freestone Grove Partners held 3,713 shares of Labcorp worth $991K as of Q1 2026.
  • Labcorp was a new Freestone Grove Partners position in Q1 2026.
  • Labcorp made up 0.01% of Freestone Grove Partners's portfolio in Q1 2026, its #481 holding.
  • Freestone Grove Partners first reported a position in Labcorp in Q4 2024 and has held it in 4 quarters since.
  • Freestone Grove Partners's Labcorp position peaked at $48.7M in Q4 2024.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.